OneMedForum to Highlight the Newest, Most Promising Med Tech Innovations
OneMedPlace announced that it will showcase to investors and entrepreneurs the newest and most promising new medical technologies in the region.
vaccines
Inhalable Drugs Let Patients Take a Breather from Needles
Earlier this month, a team of researchers led by the University of Colorado at Boulder announced that the inhalable measles vaccine they developed could lead to vaccines for other diseases.
LAMP May Light the Way to New Generation of Vaccines
LAMP (Lysosome-Associated Membrane Protein) is a gene that has been shown to enhance immune response when incorporated into a DNA vaccine.
Biotech News Out of Quebec
Medicago, a Canadian company focused on protein-based vaccines, has signed a contract with the U.S. Army to investigate ways to create biofuels from plants.
Special Report: Fighting the U.S. AIDS Epidemic
An estimated 1.2 million people in the U.S. have the HIV virus. OneMedPlace speaks with AIDS advocate Michael Manganiello about the scope of the epidemic, the possibility of a vaccine, and what needs to happen to make a national AIDS strategy a reality.
Frontrunners Emerge In Swine Flu Vaccine Race
Just days after the World Health Organization declared a swine flu pandemic, Fierce Biotech reports that two pharmaceutical companies are already racing to complete clinical trials of their H1N1 vaccines.
Companies Rush to Create Swine Flu Vaccines
With flu season approaching, the U.S. federal government has earmarked nearly $1 billion for the development of swine flu vaccines.
[Video Profile] Inovio Biomedical Corporation
Solid tumors represent 85 percent of all cancers, creating a huge clinical need for localized, site-specific cancer treatment. Inovio Medical Corporation of San Diego is developing DNA-based vaccines that harness the body’s immune system to prevent and treat chronic diseases such as cancer and HIV.